Actinium Pharmaceuticals Announced Data Was Presented At Society Of Immunotherapy Of Cancer Annual Meeting, For Actimab-A, Targeted Radiotherapeutic Comprised Of The CD33 Targeting Antibody Lintuzumab And The Actinium-225 Alpha-particle Emitting Payload

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!